We fund ground-breaking research to improve the lives of people with CASK gene related conditions and to understand more about this critical gene.
This is led by our research strategy, with the most promising projects selected using rigorous peer review by our Research Review Committee.
Our Vision
Our vision is a world where CASK gene related disorders are much better understood, the effects on the body as a whole are understood and clinicians are able to access greater and more accurate information about prognoses, progression and treatments. We envisage ultimately that there will be drugs that treat the symptoms more effectively and drugs that target the mechanisms of the disease, providing relief, allowing greater cognitive development and perhaps, one day, even curing the disease.
Applying for grants
New projects will be assessed against our project selection criteria to ensure we focus on activities that make the best use of our funds. All new projects must fall within the scope of our purpose and must pass an internal triage before progressing through the stages listed below. We follow the recommendations of the AMRC (Association of Medical Research Charities). Our research strategy is led by international professionals, key opinion leaders working in the field and those personally affected by CASK gene related disorders. All grant applications must match at least one of the criteria.
Peer review
We award our funds through a peer review process, as this is recognised as best practice in awarding research grants, with each application subject to review by independent experts in the field.
